Previous 10 | Next 10 |
MindMed Announces Compliance with Nasdaq Listing Requirements Canada NewsWire NEW YORK , Sept. 14, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing ...
Shares of the psychedelic medicine company Mind Medicine (MindMed) (NASDAQ: MNMD) tumbled by a heftly 23% through the first three and half days of trading this week, according to data from S&P Global Market Intelligence . The good news is that the novel healthcare company's ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/T. Schneider ShiftPixy (NASDAQ: PIXY ) stock is rocketing higher on Thursday after the company announced plans to spin off ShiftPixy Labs . That’s big news for investors in PIX...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Daniel Patrick Martin / Shutterstock.com MindMed (NASDAQ: MNMD ) stock is on the move Wednesday following positive data from a Phase II clinical trial of MM-120 . MM-120 is an LSD treatment in develop...
Retail investors often see stock splits as good news, as these shares become more affordable post-split. Not surprisingly, the announcement usually is accompanied by an immediate rally in the stock price. Reverse stock splits, however, have the opposite connotation, as companies usu...
The shares of Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD ), a company focused on brain disorders, climbed in the pre-market trading Thursday on the announcement of the peer-reviewed publication of data supporting its candidate for anxiety MM-120. The data published in the...
MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal Canada NewsWire - Data from University Hospital Basel (UHB) study supports the clinical development of MindMed's proprietary MM-120...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change after a psychedelic drug experience and a non-d...
MindMed to Participate in H.C. Wainwright Global Investment Conference Canada NewsWire NEW YORK , Sept. 7, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company dev...
Hot off its 1-for-15 reverse stock split on August 26, Mind Medicine (NASDAQ: MNMD) shares are hovering near $11.50, and the market's reaction to the move has been muted at best. The psychedelic therapy developer's stock is still down by more than 72.7% in the last 12 months thanks ...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...